Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02564341 · ClinicalTrials.gov registry record · NA
Targeting Effective Analgesia in Clinics for HIV - Intervention
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02564341 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 41 participants.
The verdict
NCT02564341, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The TEACH randomized controlled trial will test the effectiveness of a collaborative care intervention directed towards physicians who provide care for HIV-infected persons to improve the quality of care for prescribing chronic opioid therapy (COT) for pain and reduce the misuse of prescription opioids among HIV-infected persons.
Interventions
- BEHAVIORAL Collaboration with an IT enabled nurse care manager
- BEHAVIORAL Education and academic detailing
- BEHAVIORAL Facilitated access to a specialist in addictions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02564341
The ClinicalTrials.gov registry entry for NCT02564341 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Collaboration with an IT enabled nurse care manager is the first listed.
NCT02564341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02564341 about?
NCT02564341 is a clinical study titled "Targeting Effective Analgesia in Clinics for HIV - Intervention". The TEACH randomized controlled trial will test the effectiveness of a collaborative care intervention directed towards physicians who provide care for HIV-infected persons to improve the quality of care for prescribing chronic opioid therapy (COT) for pain and reduce the misuse of prescription opio...
What is the current status of trial NCT02564341?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-09. Estimated completion is 2018-11.
What interventions are being tested in trial NCT02564341?
The interventions under investigation include: Collaboration with an IT enabled nurse care manager (BEHAVIORAL), Education and academic detailing (BEHAVIORAL), Facilitated access to a specialist in addictions (BEHAVIORAL).
Who is sponsoring clinical trial NCT02564341?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.